Tirzepatide has emerged as a novel new treatment for individuals with type 2 diabetes. This groundbreaking medication combines the actions of two substances, GLP-1 and GIP, to effectively lower blood sugar levels. Early clinical trials have demonstrated impressive results, showing hormona del crecimiento substantial decreases in HbA1c levels and a